000963 华东医药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)11.89314.32814.21714.75420.940
总资产报酬率 ROA (%)7.2178.7758.5908.99112.350
投入资产回报率 ROIC (%)9.73611.91611.85612.57116.316

边际利润分析
销售毛利率 (%)32.55032.40031.90330.68633.051
营业利润率 (%)10.2158.5008.1178.26210.321
息税前利润/营业总收入 (%)10.0778.6588.2458.24510.354
净利润/营业总收入 (%)8.1417.0076.7156.7668.639

收益指标分析
经营活动净收益/利润总额(%)101.754102.189103.790100.29887.358
价值变动净收益/利润总额(%)-2.767-6.736-3.731-3.406-0.797
营业外收支净额/利润总额(%)-2.6000.377-1.001-0.997-0.671

偿债能力分析
流动比率 (X)1.4831.7121.7301.6711.698
速动比率 (X)1.1411.3151.2881.2421.226
资产负债率 (%)39.80435.59338.52237.24637.279
带息债务/全部投入资本 (%)18.22013.55214.20911.904--
股东权益/带息债务 (%)438.416620.086578.494712.153663.497
股东权益/负债合计 (%)147.683176.469154.613164.885162.047
利息保障倍数 (X)83.43268.70939.733129.087101.974

营运能力分析
应收账款周转天数 (天)74.68964.93065.04865.4530.000
存货周转天数 (天)58.47757.58759.36460.4240.000